Keyword: biologics

News

Syngene Acquires its First US Manufacturing Facility

11.03.2025 -

Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA –...

News

Rentschler Pulls Out of Cell and Gene Therapy

03.02.2025 -

Germany-headquartered Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of...

News

AstraZeneca to Invest $3.5 Billion in the US

14.11.2024 -

Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.

News

Specialty Pharma CDMO OneSource Recently Launched

11.10.2024 -

OneSource Specialty Pharma, a newly incorporated CDMO, formed from the merger of three CDMO businesses within the Strides Group. The company has a 30-year track record...

News

Lilly Announces New $4.5 Billion Site

03.10.2024 -

Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing...

Markets & Companies

The CDMO/CMO Report

11.09.2024 -

Driven by increased demand in biologic-based drugs, biologic drug substance manufacturing continues to be an active area of investment by contract development and...

Markets & Companies

Insights into Biologics and Pharmaceutical Manufacturing

11.09.2024 -

Bill Humphries, CEO of Alcami, shares his vision for the future, discussing dynamic market trends and the company’s commitment to innovation. Under his leadership, Alcami...

News

​​Lonza Completes Expansion of Microbial Manufacturing Facility

09.09.2024 -

Lonza recently announced that it has completed a planned expansion of the mid-scale microbial manufacturing facility at its Visp, Switzerland site. This multi-product...